ABSTRACT
Seizures are an important source of morbidity in patients with neurologic involvement in cancer. Seizures may lead to the diagnosis of a primary or secondary brain tumor, malignant leptomeningeal infiltration, neurologic paraneoplastic disorder, or metabolic dysfunction, or complication of immunosuppression such as an abscess or meningitis.
